dextropropoxyphene has been researched along with zomepirac in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honig, S; Murray, KA | 1 |
| Bullingham, RE; Evans, PJ; McQuay, HJ; Moore, RA; O'Sullivan, G; Rolfe, M | 1 |
| Fortess, EE; Gurwitz, JH; Ross-Degnan, D; Soumerai, SB | 1 |
2 trial(s) available for dextropropoxyphene and zomepirac
| Article | Year |
|---|---|
Postsurgical pain: zomepirac sodium, propoxyphene/-acetaminophen combination, and placebo.
Topics: Acetaminophen; Adolescent; Adult; Aged; Analgesics; Clinical Trials as Topic; Dextropropoxyphene; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Pain, Postoperative; Placebos; Pyrroles; Tolmetin | 1981 |
Zomepirac, placebo and paracetamol/dextropropoxyphene combination compared in orthopaedic postoperative pain.
Topics: Acetaminophen; Adolescent; Adult; Analgesics; Bone and Bones; Clinical Trials as Topic; Dextropropoxyphene; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Pain, Postoperative; Placebos; Pyrroles; Tolmetin | 1982 |
1 other study(ies) available for dextropropoxyphene and zomepirac
| Article | Year |
|---|---|
Examining product risk in context. Market withdrawal of zomepirac as a case study.
Topics: Analgesia; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Dextropropoxyphene; Drug Approval; Drug Industry; Drug Prescriptions; Drug Utilization; Family Practice; Humans; New Jersey; Practice Patterns, Physicians'; Product Surveillance, Postmarketing; Risk Factors; Tolmetin | 1993 |